Amsurg Corp Rating Reiterated by Zacks (AMSG)
Amsurg Corp (NASDAQ:AMSG)‘s stock had its “neutral” rating restated by Zacks in a research report issued to clients and investors on Friday. They currently have a $51.00 target price on the stock. Zacks‘s price target suggests a potential upside of 5.46% from the company’s current price.
Zacks’ analyst wrote, “AmSurg’s fourth-quarter 2013 adjusted EPS of $0.53 increased 1.9% year over year but lagged the Zacks Consensus estimate by $0.02. It also remained at the low end of the company provided guidance range. Revenues increased a mere 1.9% and failed to meet the estimate. However, growth through strong performances of the acquired centers was encouraging. Furthermore, the Sheridan Healthcare acquisition plan, paving its way into the huge and fast-growing fragmented physician outsourcing market is expected to be a material upside. Nonetheless, headwinds like reduction in workers’ compensation reimbursement, sequestration and increased interest expense are intimidating. We are Neutral on AmSurg.”
Several other analysts have also recently commented on the stock. Analysts at SunTrust upgraded shares of Amsurg Corp from a “neutral” rating to a “buy” rating in a research note on Friday, June 27th. They now have a $54.00 price target on the stock, up previously from $50.00. Separately, analysts at Robert W. Baird upgraded shares of Amsurg Corp from a “neutral” rating to an “outperform” rating in a research note on Friday, June 27th. They now have a $55.00 price target on the stock, up previously from $44.00. Finally, analysts at Raymond James upgraded shares of Amsurg Corp from a “market perform” rating to a “strong-buy” rating in a research note on Friday, May 30th. They now have a $60.00 price target on the stock. Four research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. Amsurg Corp has an average rating of “Buy” and a consensus target price of $52.75.
Shares of Amsurg Corp (NASDAQ:AMSG) traded up 1.83% during mid-day trading on Friday, hitting $48.36. 818,837 shares of the company’s stock traded hands. Amsurg Corp has a 52 week low of $35.27 and a 52 week high of $52.81. The stock’s 50-day moving average is $46.85 and its 200-day moving average is $45.1. The company has a market cap of $1.537 billion and a price-to-earnings ratio of 21.11.
Amsurg Corp (NASDAQ:AMSG) last announced its earnings results on Tuesday, April 22nd. The company reported $0.53 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.55 by $0.02. The company had revenue of $263.11 million for the quarter, compared to the consensus estimate of $272.09 million. During the same quarter in the prior year, the company posted $0.52 earnings per share. The company’s quarterly revenue was up 1.9% on a year-over-year basis. On average, analysts predict that Amsurg Corp will post $2.44 earnings per share for the current fiscal year.
AmSurg Corp. is the owner and operator of short stay ambulatory surgery centers (NASDAQ:AMSG) in the United States.
To view Zacks’ full report, visit Zacks’ official website.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.